Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2019-01-15
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fourier Transformed Infrared Spectroscopy in Macular Surgery
NCT03452748
Fovea ERM After Fovea-sparing ILM Peeling
NCT04445142
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
NCT05145491
Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy
NCT02528058
Characters of Epiretinal Membranes in Patients With Previous Vitrectomy for Retinal Detachment
NCT04288440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Surgical treatment: standard vitrectomy 25-27G; ERM amd ILM stainig by Membrane Blue Dual; epiretinal membrane removal, ILM peeling if the divulsion of ILM was detected.
Expected results: improving the quality of epiretinal fibrosis surgery by obtaining a more detailed picture of the pathological process
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
epiretinal membrane group
Patient with epiretinal fibrosis confirmed by OCT with BCVA\< 0,6 and complaints of metamorphopsies
Intraoperative ERM and ILM staining with their assessment and removal
ERM and ILM staining is performed after vitrectomy. After that we evaluate the condition of macular zone and make a decision to remove the ERM and the need to remove the ILM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative ERM and ILM staining with their assessment and removal
ERM and ILM staining is performed after vitrectomy. After that we evaluate the condition of macular zone and make a decision to remove the ERM and the need to remove the ILM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
82 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Makarenko Irina Romanovna
UNKNOWN
Zgoba Mariana Igorevna
UNKNOWN
The S.N. Fyodorov Eye Microsurgery State Institution
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyskin Pavel Vladimirovich, MD, PhD
MD, PhD, ophthalmosurgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pavel V Lyskin, PhD
Role: PRINCIPAL_INVESTIGATOR
The S.N. Fyodorov Eye Microsurgery State Institution
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
S.N. Fedorov Nmrc "Mntk "Eye Microsurgery"
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
124575
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.